Loss of phosphodiesterase 10A (PDE-10A) signalling is associated with progression and severity in patients with Parkinson’s disease
Niccolini F, Foltynie T, Reis Marques T, Natesan S, Kapur S, Muhlert N, Tzortzi A, Rabiner E, Gunn R, Piccini P, Politis M. Loss of phosphodiesterase 10A (PDE-10A) signalling is associated with progression and severity in patients with Parkinson’s disease. Abstract. Neurology. April 2015;84(14 Supplement). Publication Date April 2015 How Analyze was Used “Striatum (caudate and putamen)…